Furthermore, tumour-specific cytotoxicity was significantly inhibited by blocking MAb specific for HLA class I, indicating that a classical HLA-restricted CD8+ cytotoxic T cell response against tumour antigens was a major component of the response. This evidence concerns the gene CD8A and neoplasm.